Sponsor hub

University of Michigan clinical trial failures

Review 39 stopped clinical trials from University of Michigan, including disease areas, phases, and classified stop reasons.

This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 3 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.

Total stopped trials39
Likely biological signals3
Shown below39

Dominant stop reasons

OPERATIONAL
26
OTHER/UNKNOWN
10
EFFICACY/FUTILITY
3

Notable sponsors

University of Michigan
39

Related phases

Phase IV
12
Phase II
11
Unknown
7
Phase I
5
Phase III
4

Crawlable stopped-trial records

Open Explore

Showing up to 39 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.

NCT01842282: Amlexanox for Type 2 Diabetes and Obesity

Phase II Diabetes Mellitus Type 2 trial by University of Michigan. Stop reason: OPERATIONAL.

Due to limited funding, trial was suspended, intending to restart with additional funds; then preliminary results were obtained, and research moved on to placebo controlled trial. Results for both have been published.

NCT03345550: OPTIMA-TBI Pilot Study

Phase II Mild Traumatic Brain Injury trial by University of Michigan. Stop reason: OPERATIONAL.

Slow accrual of patients, lack of financial resources